Sandu Pharmaceuticals LimitedBSE: SANDUPHQ

Sandu Pharmaceuticals Limited Press Release Jul 06 2026

· Issued by Sandu Pharmaceuticals Limited

Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve 1. To place on record the demise of Shri Umesh B. Sandu(DIN:01132141), Managing Director of the Company, on 19th June, 2026, and to record the Board''s appreciation for his invaluable contribution to the Company.2. To consider and approve the appointment of a Managing Director of the Company pursuant to the demise of the erstwhile Managing Director, Late Shri Umesh B. Sandu, subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals as may be required.3. To consider and approve the reconstitution of the Committees of the Board.4. To consider and approve the appointment of an Additional Director in the capacity of an Independent Director (Non-Executive) on the Board of the Company, subject to the approval of the shareholders of the Company and such other statutory and regulatory approvals, if any, as may be required.

View Attachment

Earlier from Sandu Pharmaceuticals

All Sandu Pharmaceuticals news releases